FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11 -

Canada News News

FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11 -
Canada Latest News,Canada Headlines
  • 📰 KUSINews
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11. FDA Commissioner Dr. Robert Califf says Omicron is making more kids sick and hospitalized. Do you think young children need a third shot?

The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech’s Covid-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.

“While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer term effects, even following initially mild disease,” said FDA Commissioner Robert M. Califf, M.D.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

KUSINews /  🏆 241. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11The FDA has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Read more »

FDA approves Pfizer COVID-19 booster for children ages 5 to 11FDA approves Pfizer COVID-19 booster for children ages 5 to 11Pfizer’s COVID-19 booster shot for U.S. kids ages 5 to 11 has been approved by the FDA. Next, it will need the CDC’s final sign-off.
Read more »

FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11The FDA has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Read more »

FDA authorizes Pfizer Covid-19 booster shots for children ages 5 to 11FDA authorizes Pfizer Covid-19 booster shots for children ages 5 to 11The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's Covid-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Read more »

FDA authorizes Pfizer Covid booster for children 5 to 11 years oldFDA authorizes Pfizer Covid booster for children 5 to 11 years oldA study in February found that two doses of the vaccine offered little protection against the omicron variant.
Read more »

FDA Authorizes Pfizer Covid Booster Dose for Kids Ages 5 to 11 Years OldFDA Authorizes Pfizer Covid Booster Dose for Kids Ages 5 to 11 Years OldThe Food and Drug Administration on Tuesday authorized a Pfizer booster dose for children ages 5 through 11 years old at least five months after they complete their two-dose primary series. Dr. Peter Marks, head of the FDA division responsible for vaccines, said data increasingly shows that the protection provided by two shots wanes off over time. The FDA determined…
Read more »



Render Time: 2025-03-10 07:08:16